ABCDEFGHIJKLMNOPQRSTUVWXYZAA
1
DateCompanySpeakerPositionTopicBiologic
2
9/21AmgenRoger HartScientific Director, Process DevelopmentOverview of Drug ModalitiesOverview of Amgen pipeline, incl. fusion proteins, peptibodies, and other novel constructs
3
9/28AmgenCen XuScientific Director, NeuroscienceThe Science Behind AimovigAimovig, monoclonal antibody for prevention of chronic migraine
4
10/19ModernaAndrea CarfiHead of Research, Infectious DiseaseDevelopment of mRNA MedicinesmRNA vaccines, including COVID-19 vaccine mRNA-1273
5
10/26AlnylamEric GreenSenior Vice President, TTR FranchisesiRNA TherapeuticsPatisiran, siRNA therapy for polyneuropathy
6
11/2BeamAdam HartiganDirector of HematologyCRISPR TherapiesHematology CRISPR Therapies
7
11/9VertexPaul NegulescuDirector of San Franscisco Research SiteCystic Fibrosis Combination TherapiesTrikafta, small molecule combination therapy for cystic fibrosis
8
11/16NovartisJennifer BrogdonExec. Director, Head of Cell Therapy ResearchCell TherapiesKymriah, CAR-T cell therapy for leukemia
9
11/23Synlogic/GinkgoDavid Lubkowicz, Christian RidleyLead Strain Engineer at Synlogic, Program Lead in Organism Engineering at GinkgoSynthetic Biology TherapiesSynthetic biology therapies for PKU
10
11/30VertexAngela YenLeader of Cell and Genetic Therapies GroupGene TherapiesGene therapies
11
TBAAmgenPanelistsVariousCareers in BiotechBiotech hiring trends and panel discussion by Amgen scientists
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100